1. Private-sector consumer medication information found not consistently useful
12-23-2008
A study released recently by the U.S. Food and Drug Administration found that the printed consumer medication information (CMI) voluntarily provided with new prescriptions by retail pharmacies does not consistently provide easy-to-read, understandable information about the use and risks of medications.
2. Patenting and Innovation in Industrial Biotechnology
11-10-2008
Innovation in industrial biotechnology is strong and growing, and patents are playing a central role, according to a new staff research study by the U.S. International Trade Commission’s (ITC) Office of Industries.
Patenting and Innovation in Industrial Biotechnology uses patent data, survey results, and profiles of firms in two emerging sectors (cellulosic ethanol and bio-based plastics) to paint a new picture of innovation in industrial biotechnology.
3. Opportunities of outsourcing biopharmaceutical R&D to China
09-27-2008
The market for Research and Development (R&D) outsourcing in the biopharmaceutical industry represents a significant economic opportunity for China. The global outsourcing market, though, is highly competitive. In much of the industry literature, China is portrayed to be an increasingly important player in this market, but one that is lagging behind other developing markets, especially India.
This report offers a vision for China that reaches beyond the current models and drivers of outsourcing. This vision moves from the concept of outsourcing to one of strategic sourcing, thus paving the way to successfully competing in an industry where R&D will increasingly be performed by global companies that create nimble, virtual operating groups comprised of the best-in-class talent required for each project. How can the Chinese biopharmaceutical industry establish itself as the preferred partner in this type of competitive marketplace?
This report will address these critical issues, highlighting recommen
4. India and China as partner of choice for the western multi national companies in the era of globalisation
08-19-2008
This paper explores the potential of Indian and Chinese biopharma industries in becoming the best trading partner of western Multinational biopharma companies in the globalised world.
5. Neglected diseases drugs innovation in Indian biopharmaceutical industry: a status Report
10-09-2007
Neglected diseases such as HIV/AIDS, malaria and tuberculosis have a very strong negative impact on poor populations. New drugs are required to tackle the persistent challenge of malaria, TB and HIV etc. The paper highlights the need of such drugs and explores the efforts made towards the innovation of such drugs in India along with some commentary on the adequacy of such efforts.
6. China Life Sciences Summit · Beijing 2007
09-21-2007
The summit is proved to be another important international event of Chinese pharmaceutical industry. Chinese government officials, experts, academics and industry leaders, well-known international pharmaceutical enterprises, VCs invested enterprises and the FDA experts come together, centering on "cooperation and win-win" theme and three simultaneous tracks with six forums.
7. World Cancer Conference
09-15-2007
In 13th September, the World Cancer Conference, co-organized by IBC Conferences and Event Management Services (Shanghai) Ltd. and People's Medical Publishing House, was held at the Westin Beijing. The conference lasted two days.
8. Chinese biopharmaceutical industry in global patent regime: Path for novel drug Industry
09-11-2007
The Paper explores the positioning of the Chinese biopharma industry for its development into a novel drug industry with a special focus on the industy's ability to adopt a collaborative or partnership model as a tool for taking a successful plunge from generic to novel drug industry. This has been discussed by Strength, Weakness, Opportunities and Threat (SWOT) analysis of the industry.
9. India and China as partner of choice for the western multi national companies in the era of globalisation
08-09-2007
This paper explores the potential of Indian and Chinese biopharma industries in becoming the best trading partner of western Multinational biopharma companies in the globalised world.
10. American BioCapital Coming to Shanghai to Seek New Cooperation Model on Biotechnology
07-10-2007
On behalf of the well-known “BioCapital”—the State of Maryland, the Maryland Department of Business and Economic Development held the first economic and trade talks on biotechnology on 4th July in Shanghai, China. At the reception, delegates from Chinese and American biotechnology field candidly exchanged their opinions on several hot topics and made key-note speeches on the current situation and existing problems of biotechnology research in the two countries.